🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Just published! We proudly present "Hallmarks of Cancer: New Dimensions" by Douglas Hanahan, the third update to the seminal series. bit.ly/3GkSqZK Ludwig Cancer

❗️Last call for abstracts❗️ #ISPNO2022 abstract submission deadline is today 👇

Join us for the next broadcast of the Pediatric Tumor Board Series. The broadcast entitled Embryonal tumor with multilayered rosettes (ETMR) will occur live on March 22, 2022, 10:00-11:30 am EST. Register here: bit.ly/PedsBoard

Introducing the Brain Cancer Revengers! A team of dedicated physician scientist with only one goal: to end pediatric brain cancer as we know it. #BrainCancerAwarenessMonth Lissa C Baird Johannes Gojo @eugewang Dana-Farber Boston Children's @Ependymoma PNOC and many more

Happy to share our latest study on novel therapies against high-risk brain tumors led by JM Penninger IMBA imbavienna.bsky.social. Fantastic use of our patient-derived tumor models MedUni Wien to prove preclinical activity of novel therapeutic approaches! 🔬👇

Europaweite präklinische Testplattform für seltene Tumoren bei Kindern etabliert und für die Zukunft gesichert. MedUni Wien #CCCVienna ➡️➡️ccc.ac.at/news/singlevie…

Das Comprehensive Cancer Center Vienna (CCC) beteiligt sich an der Gründung einer gemeinnützigen GmbH, die maßgeschneiderte Therapien für aggressive Formen von #Kinderkrebs entwickeln soll. Die europäische Spitze der Kinderonkologieforschung war aus diesem Anlass an der #MedUniWien! ⬇ bit.ly/46C3Ncm

🏃‍♂️🏃‍♀️ I am proud of our amazing team of the 🎗️pediatric brain tumor center🧠 MedUni Wien and Comprehensive Cancer Center Vienna (CCC) running today's Cancer Research Run in Vienna! Making a difference for children with brain tumors in the clinics and labs - and on the running track💪

The NTRKers virtual Patient Summit, on November 9th, is less than a month away. Check out an exclusive sneak peek of the agenda! We are thrilled to bring together patients, advocates, and healthcare providers from around the world as we discuss #TRK fusion cancers.

🧠🎗️Finally out - MEMMAT provides survival benefit for a subgroup of patients suffering from recurrent medulloblastoma. Fantastic international collaboration led by @andreaspeyrl MedUni Wien Check it out here 👇 jamanetwork.com/journals/jamao…

NBTS is excited to announce that Johannes Gojo, MD, PhD, of Medical University of Vienna, is the recipient of the first-ever CERN PFA Ependymoma Translational Research Award. Learn how this grant aims to jumpstart treatment development: braintumor.org/news/new-grant…

I am honored that our project was selected!!! Big thank you to everyone making this possible National Brain Tumor Society CERN Foundation Within a great team together with Mariella Filbin @LoetschD Walter Berger we seek to find better treatments for high-risk ependymoma #epENDymoma

We are thrilled to host fantastic speakers at our 3rd Vienna Pediatric Brain Tumor Symposium. Big thank you to Carl Koschmann, Michal Zapotocky, Philipp Euskirchen, Eelco Hoving for joining our exciting meeting where we are “Translating Science to Patient Benefit” MedUni Wien

The countdown is running for day two of the 3rd Vienna Pediatric Brain Tumor Symposium MedUni Wien. We continue with excellent speakers and our first ever patient day. We are honored to welcome Johannes Rauch Of course we continue with a lot of snow globes to be awarded 🧠🎡